Shah RB - Search Results

1

Integrative molecular concept modeling of prostate cancer progression.

Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Tomlins SA, et al. Among authors: shah rb. Nat Genet. 2007 Jan;39(1):41-51. doi: 10.1038/ng1935. Epub 2006 Dec 17. Nat Genet. 2007. PMID: 17173048

2

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

3

Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Shah R, et al. Am J Pathol. 2001 May;158(5):1767-73. doi: 10.1016/S0002-9440(10)64132-6. Am J Pathol. 2001. PMID: 11337374 Free PMC article.

4

Delineation of prognostic biomarkers in prostate cancer.

Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Dhanasekaran SM, et al. Nature. 2001 Aug 23;412(6849):822-6. doi: 10.1038/35090585. Nature. 2001. PMID: 11518967 Free article.

5

Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.

Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA. Zhou M, et al. J Urol. 2001 Dec;166(6):2193-7. J Urol. 2001. PMID: 11696734

6

Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Shah RB, et al. Am J Surg Pathol. 2002 Sep;26(9):1161-8. doi: 10.1097/00000478-200209000-00006. Am J Surg Pathol. 2002. PMID: 12218572

7

Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Zhou M, Shah R, Shen R, Rubin MA. Zhou M, et al. Am J Surg Pathol. 2003 Mar;27(3):365-71. doi: 10.1097/00000478-200303000-00010. Am J Surg Pathol. 2003. PMID: 12604893

8

Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.

Kunju LP, Rubin MA, Chinnaiyan AM, Shah RB. Kunju LP, et al. Among authors: shah rb. Am J Clin Pathol. 2003 Nov;120(5):737-45. doi: 10.1309/3T3Y-0K0T-UMYH-3WY2. Am J Clin Pathol. 2003. PMID: 14608901

9

In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice.

Kalikin LM, Schneider A, Thakur MA, Fridman Y, Griffin LB, Dunn RL, Rosol TJ, Shah RB, Rehemtulla A, McCauley LK, Pienta KJ. Kalikin LM, et al. Among authors: shah rb. Cancer Biol Ther. 2003 Nov-Dec;2(6):656-60. Cancer Biol Ther. 2003. PMID: 14688471

10

Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.

Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: shah rb. Am J Pathol. 2004 Mar;164(3):787-93. doi: 10.1016/s0002-9440(10)63167-7. Am J Pathol. 2004. PMID: 14982833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters